Skip to content

Clinical trials

Withdrawn Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Withdrawn Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20052
20062
20083
20102
20122
20131
20141
20161
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group4
University of Alabama at Birmingham3
M.D. Anderson Cancer Center2
Roswell Park Cancer Institute2
AstraZeneca1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Eastern Cooperative Oncology Group1
Fox Chase Cancer Center1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial28
Ovarian Neoplasms16
Fallopian Tube Neoplasms10
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Testicular Neoplasms4
Blast Crisis3
Burkitt Lymphoma3
Congenital Abnormalities3
Hodgkin Disease3

Trials

Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.